サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：液体塞栓剤の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、適応症別、エンドユーザー別、地域別
市場調査レポート
商品コード
1420309

液体塞栓剤の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、適応症別、エンドユーザー別、地域別

Liquid Embolic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 280 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
液体塞栓剤の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、適応症別、エンドユーザー別、地域別
出版日: 2024年01月18日
発行: Fairfield Market Research
ページ情報: 英文 280 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の液体塞栓剤の市場規模は、2024年に2億7,000万米ドルなるとみられ、2031年までに約5億8,050万米ドルに達すると予測されており、年間平均成長率（CAGR）は8.9%となり、著しい成長軌道をとげるとみられています。

液体塞栓バイアルは現在、世界市場で82.7%という大きなシェアを占めています。液状塞栓製品は動静脈奇形の治療に使用され成功を収めているが、動脈瘤治療への応用は、主に親血管への液体の移行を防ぐことへの懸念から、一部の患者に限定されたままです。

世界の液体塞栓剤市場は、過去5年間、4.2％のCAGRで拡大してきました。塞栓術は、1本以上の血管や異常な血管チャネルを遮断するために用いられる低侵襲の処置です。様々な塞栓剤がカテーテルを通して血管内に導入され、特定部位への血流を阻害します。n-ブチルシアノアクリレート（NBCA）やエチルビニルアルコールコポリマーなどの液体塞栓剤は、塞栓療法において重要な役割を果たしています。

液体塞栓剤の需要は、今後10年間にかなりの割合で急増すると予想され、CAGRは約8.9%と予測されています。この成長は、2024年から2031年にかけて3億3,340万米ドルの機会増をもたらすと予測されています。液体塞栓バイアルは、液体プレフィルド注射剤と比較して、予測期間を通じて高い需要を維持すると予想されます。

腫瘍塞栓術は、世界中で腫瘍の発生率が増加していることから、液体塞栓剤メーカーにとって大きな機会となっています。この低侵襲手術は、腫瘍への血液供給を遮断するか、腫瘍を殺す治療薬を腫瘍に直接投与します。

当レポートでは、世界の液体塞栓剤市場について調査し、市場の概要とともに、製品別、適応症別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 生産高と貿易統計、2018年～2023年

第4章 価格分析、2018年～2023年

第5章 世界の液体塞栓剤市場の見通し、2018年～2031年

  • 世界の液体塞栓剤市場の見通し、製品別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界の液体塞栓剤市場の見通し、適応症別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界の液体塞栓剤市場の見通し、エンドユーザー別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界の液体塞栓剤市場の見通し、地域別、金額（100万米ドル）、数量（個）、2018年～2031年

第6章 北米の液体塞栓剤市場の見通し、2018年～2031年

第7章 欧州の液体塞栓剤市場の見通し、2018年～2031年

第8章 アジア太平洋の液体塞栓剤市場の見通し、2018年～2031年

第9章 ラテンアメリカの液体塞栓剤市場の見通し、2018年～2031年

第10章 中東・アフリカの液体塞栓剤市場の見通し、2018年～2031年

第11章 競合情勢

  • エンドユーザー別と適応症別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Johnson & Johnson
    • Wright Medical Group N.V.
    • Microvention Inc.
    • Terumo Corporation
    • Guerbet
    • Emboflu
    • Boston Medical Corporation

第12章 付録

目次

The global liquid embolic market, valued at US$ 270 million in 2024, is set to experience a significant growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 8.9% to reach a market valuation of approximately US$ 580.5 million by 2031, according to a recent market analysis by Fairfield Market.

Liquid Embolic Vials Dominate Market Share

Liquid embolic vials currently hold a substantial share of 82.7% in the global market. While liquid embolic products have been successfully used in the treatment of arteriovenous malformations, their application in aneurysm treatment remains limited to a select group of patients, primarily due to concerns about preventing the migration of the liquid to the parent vessel.

Demand Analysis and Growth Prospects

The global market for liquid embolics has expanded at a CAGR of 4.2% over the past five years. Embolization is a minimally invasive procedure used to block one or more blood vessels or abnormal vascular channels. Various embolic agents are introduced through catheters into blood vessels to inhibit blood flow to specific areas, with liquid embolic agents such as n-Butyl Cyanoacrylate (NBCA) and ethyl vinyl alcohol copolymers playing a vital role in therapeutic embolization.

The demand for liquid embolic products is expected to surge at a substantial rate over the next decade, with a projected CAGR of around 8.9%. This growth is anticipated to bring about an incremental opportunity of US$ 333.4 million from 2024 to 2031. Liquid embolic vials are expected to remain in high demand throughout the forecast period compared to liquid prefilled injectables.

Key Opportunities for Liquid Embolic Product Manufacturers

Tumor embolization presents a significant opportunity for liquid embolic product manufacturers, given the increasing incidence of tumors worldwide. This minimally invasive procedure involves shutting down the blood supply to tumors or delivering tumor-killing therapy directly to them.

Companies developing liquid embolic agents could expand their market share by pursuing regulatory approvals for indications beyond neuro interventional, tapping into the rising prevalence of cancer. Additionally, the growing demand for neurovascular embolization devices, driven by an increasing prevalence of cerebral aneurysms, offers further market growth prospects.

Advancements in research and development also provide opportunities for both emerging and established liquid embolic product suppliers to establish a strong presence in the market.

Factors Restraining Demand for Liquid Embolic Systems

While the demand for liquid embolic products is on the rise, certain challenges must be addressed. These include issues such as balloon deflation, catheter entrapment, and difficulties in deploying the device to the targeted lesion. Moreover, the high risk associated with liquid embolic procedures, including the potential of targeting the wrong blood vessels during surgical procedures, is a concern.

Additionally, limited liquid embolic agent manufacturers face intense competition from alternative transcatheter embolization devices, which could potentially restrain the growth of the liquid embolic systems market.

Country-wise Insights

The U.S.: Largest Regional Liquid Embolic Market

The United States dominates the North America liquid embolic market, with a substantial market share. This dominance is driven by factors such as unhealthy lifestyle habits, including junk food consumption, smoking, and alcohol use, as well as a sedentary lifestyle. These habits have led to a higher prevalence of chronic diseases like high blood pressure, migraines, and bAVM, increasing the demand for liquid embolic products and agents in the U.S. Moreover, lifestyle changes have been associated with a significant percentage of cancer cases in the country, further contributing to the demand for such products.

Germany: A Lucrative Market in Europe

Germany is expected to be a prominent player in the European market for liquid embolics. This is primarily due to the substantial number of clinical trials and research conducted in the country, particularly in the field of cancer research. Germany boasts a significant number of research ethics committees, with active government involvement in healthcare and cancer-related research and innovation. This environment presents lucrative opportunities for suppliers of liquid embolic products to grow in the market.

South Korea: An Emerging Market

South Korea is an emerging market in the East Asia liquid embolic market. The country is witnessing substantial growth in this sector, mainly due to the increasing prevalence of cardiovascular diseases. For instance, coronary heart disease-related deaths in South Korea have been a significant concern. This growth in cardiovascular issues has led to a rising demand for liquid embolic products and is expected to continue to expand in the coming years.

Competitive Analysis

Leading liquid embolic product providers are adopting growth strategies such as new product launches, approvals, agreements, collaborations, and partnerships. These strategies are helping key stakeholders expand their geographic footprint and strengthen their existing product portfolios.

Key Companies Profiled:

  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Johnson & Johnson
  • Microvention Inc.
  • Terumo Corporation
  • Guerbet
  • Emboflu

Key Segments Covered in Liquid Embolic Industry Research

Liquid Embolic Market by Product

  • Liquid Embolic Vials
  • Liquid Embolic Prefilled Injectables

Liquid Embolic Market by Indication

  • Brain Arterio-Venous Malformations (bAVM)
  • Tumor Embolization
  • Radiology
  • Cardiology

Liquid Embolic Market by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Speciality Centres

Liquid Embolic Market by Region

  • North America Liquid Embolic Market
  • Latin America Liquid Embolic Market
  • Europe Liquid Embolic Market
  • East Asia Liquid Embolic Market
  • South Asia Liquid Embolic Market
  • Oceania Liquid Embolic Market
  • Middle East & Africa (MEA) Liquid Embolic Market

Table of Contents

1. Executive Summary

  • 1.1. Global Liquid Embolic Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Liquid Embolic Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Liquid Embolic Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Liquid Embolic Market Outlook, 2018 - 2031

  • 5.1. Global Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Liquid Embolic Vials
      • 5.1.1.2. Liquid Embolic Prefilled Injectables
  • 5.2. Global Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 5.2.1.2. Tumor Embolization
      • 5.2.1.3. Radiology
      • 5.2.1.4. Cardiology
  • 5.3. Global Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Ambulatory Surgical Centers
      • 5.3.1.3. Independent Speciality Centres
  • 5.4. Global Liquid Embolic Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Liquid Embolic Market Outlook, 2018 - 2031

  • 6.1. North America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Liquid Embolic Vials
      • 6.1.1.2. Liquid Embolic Prefilled Injectables
  • 6.2. North America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 6.2.1.2. Tumor Embolization
      • 6.2.1.3. Radiology
      • 6.2.1.4. Cardiology
  • 6.3. North America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Ambulatory Surgical Centers
      • 6.3.1.3. Independent Speciality Centres
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Liquid Embolic Market Outlook, 2018 - 2031

  • 7.1. Europe Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Liquid Embolic Vials
      • 7.1.1.2. Liquid Embolic Prefilled Injectables
  • 7.2. Europe Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 7.2.1.2. Tumor Embolization
      • 7.2.1.3. Radiology
      • 7.2.1.4. Cardiology
  • 7.3. Europe Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Ambulatory Surgical Centers
      • 7.3.1.3. Independent Speciality Centres
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Liquid Embolic Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Liquid Embolic Vials
      • 8.1.1.2. Liquid Embolic Prefilled Injectables
  • 8.2. Asia Pacific Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 8.2.1.2. Tumor Embolization
      • 8.2.1.3. Radiology
      • 8.2.1.4. Cardiology
  • 8.3. Asia Pacific Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Ambulatory Surgical Centers
      • 8.3.1.3. Independent Speciality Centres
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Liquid Embolic Market Outlook, 2018 - 2031

  • 9.1. Latin America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Liquid Embolic Vials
      • 9.1.1.2. Liquid Embolic Prefilled Injectables
  • 9.2. Latin America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 9.2.1.2. Tumor Embolization
      • 9.2.1.3. Radiology
      • 9.2.1.4. Cardiology
  • 9.3. Latin America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Ambulatory Surgical Centers
      • 9.3.1.3. Independent Speciality Centres
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Liquid Embolic Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Liquid Embolic Vials
      • 10.1.1.2. Liquid Embolic Prefilled Injectables
  • 10.2. Middle East & Africa Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 10.2.1.2. Tumor Embolization
      • 10.2.1.3. Radiology
      • 10.2.1.4. Cardiology
  • 10.3. Middle East & Africa Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Ambulatory Surgical Centers
      • 10.3.1.3. Independent Speciality Centres
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Indication Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Medtronic
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Meril Life Sciences Pvt. Ltd.
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Johnson & Johnson
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Wright Medical Group N.V.
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Microvention Inc.
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Terumo Corporation
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Guerbet
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Emboflu
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Boston Medical Corporation
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations